Mansour, G.K.; Altebainawi, A.F.; Hajjar, A.W.; Sayed, S.B.H.; Alazem, F.A.; Sajid, M.R.
Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Targeting Sarcomeric Hypercontractility with Demonstrated Long-Term Safety and Efficacy—A Narrative Review. J. Clin. Med. 2025, 14, 8594.
https://doi.org/10.3390/jcm14238594
AMA Style
Mansour GK, Altebainawi AF, Hajjar AW, Sayed SBH, Alazem FA, Sajid MR.
Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Targeting Sarcomeric Hypercontractility with Demonstrated Long-Term Safety and Efficacy—A Narrative Review. Journal of Clinical Medicine. 2025; 14(23):8594.
https://doi.org/10.3390/jcm14238594
Chicago/Turabian Style
Mansour, Ghaith K., Ali F. Altebainawi, Ahmad W. Hajjar, Sabry Babiker H. Sayed, Fares A. Alazem, and Muhammad Raihan Sajid.
2025. "Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Targeting Sarcomeric Hypercontractility with Demonstrated Long-Term Safety and Efficacy—A Narrative Review" Journal of Clinical Medicine 14, no. 23: 8594.
https://doi.org/10.3390/jcm14238594
APA Style
Mansour, G. K., Altebainawi, A. F., Hajjar, A. W., Sayed, S. B. H., Alazem, F. A., & Sajid, M. R.
(2025). Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Targeting Sarcomeric Hypercontractility with Demonstrated Long-Term Safety and Efficacy—A Narrative Review. Journal of Clinical Medicine, 14(23), 8594.
https://doi.org/10.3390/jcm14238594
